AI Article Synopsis
- The study investigates the metabolome and lipidome profiles of patients with primary sclerosing cholangitis (PSC) to aid in diagnosis and personalized treatment.
- Using NMR spectroscopy, researchers analyzed 33 PSC patients and found distinctive metabolic changes compared to healthy controls and patients with inflammatory bowel disease (IBD).
- Key findings include higher levels of pyruvic acid and certain lipoprotein subfractions in PSC patients, which could enhance the differentiation of PSC from IBD and other related conditions.
Article Abstract
Intoduction: Identification of specific metabolome and lipidome profile of patients with primary sclerosing cholangitis (PSC) is crucial for diagnosis, targeted personalized therapy, and more accurate risk stratification.
Methods: Nuclear magnetic resonance (NMR) spectroscopy revealed an altered metabolome and lipidome of 33 patients with PSC [24 patients with inflammatory bowel disease (IBD) and 9 patients without IBD] compared with 40 age-, sex-, and body mass index (BMI)-matched healthy controls (HC) as well as 64 patients with IBD and other extraintestinal manifestations (EIM) but without PSC.
Results: In particular, higher concentrations of pyruvic acid and several lipoprotein subfractions were measured in PSC in comparison to HC. Of clinical relevance, a specific amino acid and lipid profile was determined in PSC compared with IBD and other EIM.
Discussion: These results have the potential to improve diagnosis by differentiating PSC patients from HC and those with IBD and EIM.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11184724 | PMC |
| http://dx.doi.org/10.3389/fmed.2024.1334865 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!